enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Vortioxetine - Wikipedia

   en.wikipedia.org/wiki/Vortioxetine

   Vortioxetine was under development for the treatment of generalized anxiety disorder [59] and attention-deficit hyperactivity disorder (ADHD) [60] but development for these indications was discontinued. [61] As of August 2021, vortioxetine remains in development for the treatment of anxiety disorders, binge-eating disorder, and bipolar disorder ...

3. List of investigational social anxiety disorder drugs - Wikipedia

   en.wikipedia.org/wiki/List_of_investigational...

   This is a list of investigational social anxiety disorder drugs, or drugs that are currently under development for clinical use in the treatment of social anxiety disorder (SAD; or social phobia) but are not yet approved. Chemical/generic names are listed first, with developmental code names, synonyms, and brand names in parentheses.

4. How to Get These Anxiety Meds From a Doctor - AOL

   www.aol.com/different-types-anxiety-meds-them...

   Anxiety Medications: An Overview. Anxiety disorders are very common, according to the National Institute of Mental Health. An estimated 31.1 percent of all American adults will experience some ...

5. List of investigational anxiolytics - Wikipedia

   en.wikipedia.org/wiki/List_of_investigational...

   MDMA (Midomafetamine, 3,4-methylenedioxymethamphetamine, "ecstasy") – serotonin–norepinephrine–dopamine releasing agent and 5-HT 1 and 5-HT 2 receptor agonist – specifically under development as an aid to psychotherapy for post-traumatic stress disorder [12] [13] [14]

6. Clonazepam, popular anxiety-reducing drug, recalled ... - AOL

   www.aol.com/news/clonazepam-popular-anxiety...

   The anxiety-reducing drug, Clonazepam, has been recalled after a potentially "life-threatening" label mix-up, the Food and Drug Administration (FDA) said. According to a release from the federal ...

7. Antiplatelet drug - Wikipedia

   en.wikipedia.org/wiki/Antiplatelet_drug

   Antiplatelet therapy with one or more of these drugs decreases the ability of blood clots to form by interfering with the platelet activation process in primary hemostasis. Antiplatelet drugs can reversibly or irreversibly inhibit the process involved in platelet activation resulting in decreased tendency of platelets to adhere to one another ...